Shopping Cart
- Remove All
- Your shopping cart is currently empty
SK1-IN-1 is an orally available and potent sphingosine kinase 1 (SPHK1) inhibitor (IC50: 58 nM), with potential anticancer activity, and can be used to study cancer and neurodegenerative diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $216 | In Stock | |
1 mL x 10 mM (in DMSO) | $305 | In Stock |
Description | SK1-IN-1 is an orally available and potent sphingosine kinase 1 (SPHK1) inhibitor (IC50: 58 nM), with potential anticancer activity, and can be used to study cancer and neurodegenerative diseases. |
Targets&IC50 | SPHK1:58 nM |
In vitro | SK1-IN-1 can inhibit sphingosine kinase 1 (SPHK1) with an IC50 value of 58 nM. |
In vivo | b>METHODS: SK1-IN-1 (1 mg/kg, intravenous injection; 3 mg/kg, oral administration) was studied for its pharmacokinetic properties in rats. RESULTS: SK1-IN-1 showed moderate oral bioavailability and acceptable blood circulation half-life. The bioavailability of SK1-IN-1 in rats after oral administration was 17.6%, and the half-lives in rat blood circulation after intravenous injection and oral administration were 4.30 hours and 7.5 hours, respectively. [1] |
Molecular Weight | 398.5 |
Formula | C22H30N4O3 |
Cas No. | 1218816-71-7 |
Smiles | C(CC1CCCC1)C2=NC(=NO2)C3=CC=C([C@@H](NC(=O)[C@@H]4[C@@H](O)CCN4)C)C=C3 |
Relative Density. | 1.200 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (200.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.